Even in Africa's most populous country, attitudes about family size oare starting to shift. The change in thinking is most striking in Nigeria's Muslim and conservative north.

Anthropic postponing the release of its new AI model Claude Mythos, said to be so skilled at coding it could be a wicked ...

Discover Vijay Deverakonda's fierce portrayal of a royal rebel driven by anger in the upcoming period drama 'Ranabaali'.

Anthropic launched Claude in July 2023. Three years later, the chatbot is garnering lots of attention — and locked in a ...

Key Takeaways The quantum computing industry faces a global talent shortage, with only one qualified candidate for every ...

Early in the Covid-19 pandemic, the governor of New Jersey made an unusual admission: He’d run out of COBOL developers. The state’s unemployment insurance systems were written in the 60-year-old ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

Fierce Healthcare's Fierce 15 is one of our favorite projects each year. Now in its eighth year, the list highlights companies bringing new ideas and innovation to some of healthcare’s most persistent ...

Add Popular Science (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Get the Popular ...

The Napa Valley Expo team recently represented the Napa Town and Country Fair at the Western Fairs Association Convention in Reno, Nevada. The Napa Valley Expo earned first place in multiple ...

Programming is the backbone of modern technology, and understanding a programming languages list is essential for developers, students, and tech enthusiasts. In 2026, Python leads AI and data science ...

In the past three weeks, a flurry of licensing deals with Chinese biotechs were announced featuring AbbVie, AstraZeneca, Servier, Sanofi and Ipsen. Shionogi also beefed up its rare disease portfolio ...